Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
U.S. Better Able to Tackle Health Emergencies: ReportFirst Opioid Lawsuit Targeting Pharmacy Benefit ManagersMost Doctors' Offices Don't Offer Flexibility for UninsuredSafety Info for Opioids Found LackingNonoptimized Drug Therapy Costs More Than $500 Billion AnnuallyFDA Cracks Down on Caffeine-Loaded SupplementsCigarette Tax Hike Could Ease Poverty for Millions Worldwide: StudyCDC: Aggressive Action Needed to Contain Antibiotic ResistanceCould Medical Pot Help Curb the Opioid Abuse Crisis?Medical E-Records Not Without Risks: StudyHealth Groups Sue FDA to Speed Review of E-CigarettesEHR Usability Contributes to Possible Patient Harm EventsAHA: Solving the Dilemma of Not Enough HeartsUnchecked Air Pollution a Death Sentence for Millions: StudyPersonal Health Info Found in Recycling at Five HospitalsTask Force Issues Stronger Skin Cancer Prevention GuidelinesFDA Considers Lowering Nicotine Levels in CigarettesDoctors Facing Challenge to Help Needy While Protecting PracticesPharmacists Encouraged to Learn More About Herbal SupplementsBan Menthols to Help Some Smokers QuitStem Cell Clinics Pitch Pricey, Bogus 'Cures' for Knee PainMany Americans Think Docs Order Too Many Tests, MedsIs Herbal Drug Kratom a Health Friend or Foe?Early Studies Often Show Exaggerated Treatment EffectStrong Tobacco Laws May Weed Out Vapers, TooUnderstanding Rx Nonadherence Can Improve AdherenceBystander Use of Defib Device Doubles Chances of Surviving Cardiac ArrestNew Research Debunks Two Medical Marijuana MythsTake Early Clinical Trials With a Grain of SaltCould Hackers Target Heart Devices?Protecting Your Electronic Health RecordsAfter Another Shooting Tragedy, 'Stop the Bleed' Kits Urged for SchoolsPatients Want Physicians to Have Greater ConnectivityYour Tax Dollars Fund Research on Hundreds of New MedsFour Best Practices Outlined to Prevent Health Care CyberattacksMany Patients Know Too Little About Their MRI, CT Scans: StudyUnsafe Water Found in Faucets Across the U.S.Health Tip: Prevent Exposure to LeadHealth Tip: Online Pharmacies You Should AvoidDon't Count on an American to Do CPRPoll: Personal Beliefs Shouldn't Allow Doctors to Refuse to TreatFDA Says U.S. Will Now Produce Critical MRI ComponentPicking a New Primary Care DoctorUber, Lyft Rides May Not Help Boost Doc Visits for Poorer Patients2018 Immunization Schedule Issued for U.S. ChildrenA Hidden Source of 'Superbugs' in Hospitals?2018 Immunization Schedule Issued for U.S. AdultsTop Three Challenges Identified for Pharmacists in 2018Responding to Opioid Crisis, FDA Puts More Restrictions on ImodiumMonkey Deaths Prompt FDA Probe, New Controls on Animal Research
Questions and AnswersLinksBook Reviews
Related Topics

Monkey Deaths Prompt FDA Probe, New Controls on Animal Research

HealthDay News
by -- Robert Preidt
Updated: Jan 26th 2018

new article illustration

FRIDAY, Jan. 26, 2018 (HealthDay News) -- A U.S. government study using monkeys to investigate nicotine addiction has been halted and an investigation launched after four monkeys died.

In the wake of the deaths, the Food and Drug Administration said Friday that it is reviewing its rules on animal studies and has created a new council to oversee them.

The study at the FDA's National Center for Toxicological Research (NCTR) used squirrel monkeys to gauge how various levels of nicotine affect the risk of addiction in teens and young adults.

No new studies will begin at the NCTR until the investigation is complete, FDA Commissioner Dr. Scott Gottlieb said. The surviving monkeys will be placed in a permanent sanctuary home, he added.

"The FDA has a deep commitment to ensuring the responsible and humane care of animals when research involving animals is needed to fulfill the agency's public health mission. The FDA also is fully committed to complying with the rules and guidance governing animal research," Gottlieb said in a statement.

After learning about the monkey deaths and other concerns, Gottlieb said he immediately stopped the study. He also asked the FDA's Principal Deputy Commissioner to lead a review of the well-being of animals involved in the study and the circumstances surrounding the four deaths.

Gottlieb also ordered an independent, third-party probe of all of the FDA's animal research programs.

A new Animal Welfare Council will oversee all animal research studies and facilities under FDA control. It will advise the FDA on its approach to animal welfare and ensure animal studies meet the agency's standards, according to the statement.

The FDA will also "reaffirm and strengthen our commitment to replacing, reducing, and/or refining animal studies," Gottlieb said.

He added, however, that there remain many areas where animal research is important and necessary.

"We understand and share concerns that animals be involved in research only when there is no other way to fulfill an important public health objective. And, when these studies are necessary, the animals involved in research must be cared for under strict, humane guidelines," Gottlieb stated.

"I am committed to ensuring an effective, humane and judicious animal research program at FDA, and I will continue to communicate with our stakeholders on our efforts," he concluded.

More information

The Humane Society of the United States has more on the use of animals in research.